Work

Genomic signature–based risk score for PARP inhibitor response in BRCA -mutated ovarian cancer: A whole-exome sequencing analysis.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.5547

Authors: Junhwan Kim, Jong Kwang Kim, Myong Cheol Lim, Sang-Soo Seo, Sang-Yoon Park, Junyoung Shin, Chong Woo Yoo, Sokbom Kang

Institution: National Cancer Center

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162519349

Cites:

Cited by:

Related to: